Excess apoptosis of mononuclear cells contributes to the depressed cytomegalovirus-specific immunity in HIV-infected patients on HAART

Virology

Volumn 330, Issue 1, 2004, Pages 313-321

  Weinberg, Adriana ^a,b   Jesser, Renee D ^a   Edelstein, Charles L ^b   Bill, Jerome R ^b   Wohl, David A ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Annexin V; Apoptosis; Caspase; Cell mediated immunity; crmA; Cytomegalovirus; HAART; HIV; Immune reconstitution

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE 3; CASPASE 8; CASPASE 9;

APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS REPLICATION;

ANNEXIN A5; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CYSTEINE PROTEINASE INHIBITORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 7444247875     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.09.017     Document Type: Article

References (40)

1. Y. Adachi, N. Oyaizu, S. Than, T.W. McCloskey, and S. Pahwa IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2 J. Immunol. 157 1996 4184 4193
2. A. Alam, L.Y. Cohen, S. Aouad, and R.P. Sekaly Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells J. Exp. Med. 190 1999 1879 1890
3. B. Autran, G. Carcelain, T.S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease Science 277 1997 112 116
4. A.D. Badley, D.H. Dockrell, A. Algeciras, S. Ziesmer, A. Landay, M.M. Lederman, E. Connick, H. Kessler, D. Kuritzkes, D.H. Lynch, P. Roche, H. Yagita, and C.V. Paya In vivo analysis of Fas/FasL interactions in HIV-infected patients J. Clin. Invest. 102 1998 79 87
5. P. Bouillet, J.F. Purton, D.I. Godfrey, L.C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J.M. Adams, and A. Strasser BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes Nature 415 2002 922 926
6. H.J. Chun, L. Zheng, M. Ahmad, J. Wang, C.K. Speirs, R.M. Siegel, J.K. Dale, J. Puck, J. Davis, C.G. Hall, S. Skoda-Smith, T.P. Atkinson, S.E. Straus, and M.J. Lenardo Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency Nature 419 2002 395 399
7. L. Cosmi, F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, E. Maggi, S. Romagnani, and F. Annunziato Human CD8+ CD25+ thymocytes share phenotypic and functional features with CD4+ CD25+ regulatory thymocytes Blood 102 2003 4107 4114
8. L.M. de Oliveira Pinto, H. Lecoeur, E. Ledru, C. Rapp, O. Patey, and M.L. Gougeon Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro AIDS 16 2002 329 339
9. A.S. Fauci, S.M. Schnittman, G. Poli, S. Koenig, and G. Pantaleo NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection Ann. Intern. Med. 114 1991 678 693
10. D. Genini, D. Sheeter, S. Rought, J.J. Zaunders, S.A. Susin, G. Kroemer, D.D. Richman, D.A. Carson, J. Corbeil, and L.M. Leoni HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism FASEB J. 15 2001 5 6
11. S.M. Hammer, K.E. Squires, M.D. Hughes, J.M. Grimes, L.M. Demeter, J.S. Currier, J.J. Eron Jr., J.E. Feinberg, H.H. Balfour Jr., L.R. Deyton, J.A. Chodakewitz, and M.A. Fischl A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team N. Engl. J. Med. 337 1997 725 733
12. C. Iyasere, J.C. Tilton, A.J. Johnson, S. Younes, B. Yassine-Diab, R.P. Sekaly, W.W. Kwok, S.A. Migueles, A.C. Laborico, W.L. Shupert, C.W. Hallahan, R.T. Davey Jr., M. Dybul, S. Vogel, J. Metcalf, and M. Connors Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2 J. Virol. 77 2003 10900 10909
13. D.A. Jabs, S.G. Bolton, J.P. Dunn, and A.G. Palestine Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy Am. J. Ophthalmol. 1998
14. M.A. Jacobson, H. Stanley, C. Holtzer, T.P. Margolis, and E.T. Cunningham Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy Clin. Infect. Dis. 30 2000 231 233
15. S. Jaleco, L. Swainson, V. Dardalhon, M. Burjanadze, S. Kinet, and N. Taylor Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis J. Immunol. 171 2003 61 68
16. W. Janssens, V. Carlier, B. Wu, L. VanderElst, M.G. Jacquemin, and J.M. Saint-Remy CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner J. Immunol. 171 2003 4604 4612
17. M.P. Karavellas, C.Y. Lowder, C. Macdonald, C.P. Avila Jr., and W.R. Freeman Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome Arch. Ophthalmol. 116 1998 169 175
18. M.P. Karavellas, D.J. Plummer, J.C. Macdonald, F.J. Torriani, C.L. Shufelt, S.P. Azen, and W.R. Freeman Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy J. Infect. Dis. 179 1999 697 700
19. A.R. Khaled, and S.K. Durum Lymphocide: cytokines and the control of lymphoid homeostasis Nat. Rev., Immunol. 2 2002 817 830
20. H.M. Lederman, P.L. Williams, J.W. Wu, T.G. Evans, S.E. Cohn, J.A. McCutchan, S.L. Koletar, R. Hafner, E. Connick, F.T. Valentine, M.J. McElrath, N.J. Roberts Jr., and J.S. Currier Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion J. Infect. Dis. 188 2003 1794 1803
21. J.J. Lum, A.A. Pilon, J. Sanchez-Dardon, B.N. Phenix, J.E. Kim, J. Mihowich, K. Jamison, N. Hawley-Foss, D.H. Lynch, and A.D. Badley Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l J. Virol. 75 2001 11128 11136
22. J.C. Macdonald, F.J. Torriani, L.S. Morse, M.P. Karavellas, J.B. Reed, and W.R. Freeman Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy J. Infect. Dis. 177 1998 1182 1187
23. V.Y. Melnikov, T. Ecder, G. Fantuzzi, B. Siegmund, M.S. Lucia, C.A. Dinarello, R.W. Schrier, and C.L. Edelstein Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure J. Clin. Invest. 107 2001 1145 1152
24. V.Y. Melnikov, S. Faubel, B. Siegmund, M.S. Lucia, D. Ljubanovic, and C.L. Edelstein Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice J. Clin. Invest. 110 2002 1083 1091
25. N. Najafian, T. Chitnis, A.D. Salama, B. Zhu, C. Benou, X. Yuan, M.R. Clarkson, M.H. Sayegh, and S.J. Khoury Regulatory functions of CD8+ CD28- T cells in an autoimmune disease model J. Clin. Invest. 112 2003 1037 1048
26. F.J. Palella Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman, and S.D. Holmberg Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N. Engl. J. Med. 338 1998 853 860
27. L.T. Quan, A. Caputo, R.C. Bleackley, D.J. Pickup, and G.S. Salvesen Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A J. Biol. Chem. 270 1995 10377 10379
28. N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, J.P. Vaillancourt, K.T. Chapman, and D.W. Nicholson A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis J. Biol. Chem. 272 1997 17907 17911
29. J.A. Trapani, and M.J. Smyth Functional significance of the perforin/granzyme cell death pathway Nat. Rev., Immunol. 2 2002 735 747
30. H. Valdez, E. Connick, K.Y. Smith, M.M. Lederman, R.J. Bosch, R.S. Kim, M. St. Clair, D.R. Kuritzkes, H. Kessler, L. Fox, M. Blanchard-Vargas, and A. Landay Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease AIDS 16 2002 1859 1866
31. A. Weinberg, R.A. Betensky, L. Zhang, and G. Ray Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients Clin. Diagn. Lab. Immunol. 5 1998 804 807
32. A. Weinberg, D.A. Wohl, D.G. Brown, G.B. Pott, L. Zhang, M.G. Ray, and C. van der Horst Effect of cryopreservation on measurement of cytomegalovirus- specific cellular immune responses in HIV-infected patients J. Acquired Immune Defic. Syndr. 25 2000 109 114
33. A. Weinberg, D.A. Wohl, R.J. Barrett, and C. van der Horst Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy J. Infect. Dis. 184 2001 707 712
34. A. Weinberg, S.A. Nachman, P. Gona, P. Defechereux, R. Yogev, W. Hughes, D. Warea, C. Elgie, M. Cooper, W. Dankner PACTG 1008 Team Antibody responses to hepatitis: A virus vaccine (HAVV) among HIV-infected children with evidence of immunologic reconstitution [abstract 915] Program and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco) vol. 406 2003
35. A. Weinberg, D.A. Wohl, S. MaWhinney, R.J. Barrett, D.G. Brown, N. Glomb, and C. van der Horst Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy AIDS 17 2003 2445 2450
36. A. Weinberg, S. Pahwa, R. Oyomopito, V.J. Carey, B. Zimmer, L. Mofenson, A. Kovacs, S.K. Burchett PACTG 366 Team Antimicrobial-specific cell-mediated immunity in HIV-infected children on HAART Clin. Infect. Dis. 39 2004 102 114
37. A. Weinberg, A.A. Wiznia, B.J. LaFleur, S. Shah, and M.J. Levin Varicella-zoster virus-specific cell-mediated immunity in HIV-infected children on HAART J. Infect. Dis. 190 2004 267 270
38. S.M. Whitcup, E. Fortin, A.S. Lindblad, P. Griffiths, J.A. Metcalf, M.R. Robinson, J. Manischewitz, B. Baird, C. Perry, I.M. Kidd, T. Vrabec, R.T. Davey Jr., J. Falloon, R.E. Walker, J.A. Kovacs, H.C. Lane, R.B. Nussenblatt, J. Smith, H. Masur, and M.A. Polis Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis JAMA 282 1999 1633 1637
39. J.J. Zaunders, L. Moutouh-de Parseval, S. Kitada, J.C. Reed, S. Rought, D. Genini, L. Leoni, A. Kelleher, D.A. Cooper, D.E. Smith, P. Grey, J. Estaquier, S. Little, D.D. Richman, and J. Corbeil Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2 J. Infect. Dis. 187 2003 1735 1747
40. M.E. Zegans, R.C. Walton, G.N. Holland, J.J. O'Donnell, M.A. Jacobson, and T.P. Margolis Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis Am. J. Ophthalmol. 125 1998 292 300